Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions by Santos, Helton et al.
European Journal of Pharmaceutical Sciences 21 (2004) 271–281
Compaction, compression and drug release characteristics of xanthan
gum pellets of different compositions
Helton Santos∗, Francisco Veiga, Ma Eugénia Pina, João José Sousa
Faculdade de Farmácia, Centro de Estudos Farmaceˆuticos, Universidade de Coimbra, Rua do Norte, 3000-295 Coimbra, Portugal
Received 10 March 2003; received in revised form 13 October 2003; accepted 22 October 2003
Abstract
Compaction and compression of xanthan gum (XG) pellets were evaluated and drug release from tablets made of pellets was characterised.
Three formulations were prepared by extrusion–spheronisation and included, among other excipients, diclofenac sodium (Dic Na), at 10%
(w/w); xanthan gum, at 16% (w/w); and one of three different fillers (lactose monohydrated (LAC), tribasic calcium phosphate (TCP) and
-cyclodextrin (-CD)), at 16% (w/w). Five hundred milligrams of pellets (fraction 1000–1400m) were compacted in a single punch
press at maximum punch pressure of 125 MPa using flat-faced punches (diameter of 1.00 cm). Physical properties of pellets and tablets
were analysed. Dissolution was performed according to the USP paddle method. Pellets showed close compressibility degrees (49.27% LAC;
51.32% TCP; and 50.48%-CD) but densified differently (3.57% LAC; 14.84% TCP; 3.26%-CD). Permanent deformation and densification
were the relevant mechanisms of compression. Fragmentation was regarded as non-existent. The release behaviour of tablets made of pellets
comprising LAC or -CD was anomalous having diffusional exponent (n) values of 0.706 and 0.625, respectively. Drug diffusion and erosion
were competing mechanisms of drug release from those tablets.
© 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Tablets are the most common and popular form of phar-
maceutical dosage forms. These solid units usually consist
of a mixture of fine powders compacted in a die at an applied
pressure to provide a single rigid body of defined mechan-
ical strength (Marshall and Rudnick, 1990). Most recently,
there has been an increasing interest in the development of
multiparticulate dosage forms in the shape of tablets instead
of hard gelatine capsules, as an attempt to overcome the
high production costs (Marshall and Rudnick, 1990; Çelik,
1994).
In the field of tablets made of multiparticulates, the
goal of many investigations has been the search of rea-
sonable knowledge about the mechanisms involved dur-
ing compaction of such units (Johansson et al., 1995,
1998; Johansson and Alderborn, 1996, 2001). The com-
mon approach is the use of granules as a model system
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(Wikberg and Alderborn, 1990a,b, 1991, 1992a,b, 1993).
It is suggested that four mechanisms are involved in the
compression process of irregular granules: fragmenta-
tion, deformation, densification and attrition (Çelik, 1994;
Johansson et al., 1995). Those mechanisms are related to
the structural changes of the model system rather than to the
forming primary particles. In spite of the knowledge that
has been gathered by using granules in compaction studies,
the establishment of better knowledge of the extent of com-
pression involves some complexity due to the occurrence
of fragmentation and attrition as a result of the irregular
shape and surface roughness of these units. Reasonably,
the well-defined shape of pellets enables the improvement
of the mechanistic knowledge of the compaction process
of porous particles and justifies their use as an alternative
model system (Johansson et al., 1995). Furthermore, the de-
sign of active drug pellets as well as the choice of suitable
ingredients for their production find great contribution on
the better comprehension of volume reduction behaviour of
such units.
The purpose of this study was to investigate the effect of
the physical properties (shape, surface roughness, specific
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surface area, mechanical tensile strength, porosity and
pore structure) of matrix pellets on the compression be-
haviour and tablet forming ability of these units (Johansson
et al., 1995, 1998; Johansson and Alderborn, 1996, 2001;
Nicklasson et al., 1999a,b). For that purpose, pellets were
prepared comprising xanthan gum (XG) as the hydrophilic
polymer and one of three different fillers in their formula-
tions. Pellets were also assessed for their degrees of com-
pression and densification and tablets made of pellets were
considered for the determination of the mechanical tensile
strength, total porosity, appearance of the upper and fracture
surfaces in an attempt to add and/or confirm knowledge
to the compression mechanism of nearly spherical units
formed from other materials than only microcrystalline
cellulose (Johansson et al., 1995, 1998; Johansson and
Alderborn, 1996, 2001) or binary mixtures of microcrys-
talline cellulose and filler (Nicklasson et al., 1999a,b).
Specifically, this work intends to answer whether pellets
prepared in the same way, bearing similar physical charac-
teristics but differing in the type of one of their constituents
would differ in their compaction mode. Moreover, disso-
lution behaviour and drug release from the tablets were
investigated in order to derive information for the choice of
pellets formulation suitable for tabletting and simultaneously
presenting appropriate control release of the active model
drug.
Xanthan gum, here employed as the control release agent,
is a high molecular weight heteropolyssaccharide gum pro-
duced by a pure culture fermentation of a carbohydrate with
the microorganism Xanthamonas campestris. It has been
widely used in oral and topical formulations, cosmetics and
food (Wade and Weller, 1994). More recently it has been
proven to play a successful role in sustaining release of
drugs from hydrophilic matrix formulations (Lu et al., 1991;
Talukdar and Plaizier-Vercammen, 1993; Ingani and Moës,
1998). Furthermore, xanthan gum has proved to have higher
drug-retarding ability compared to the well-known hydroxy-
propylmetyl cellulose (Talukdar et al., 1996; Talukdar and
Kinget, 1997).
2. Materials
Diclofenac sodium (Dic Na) (BP grade) was purchased
from Capsifar, Oeiras, Portugal and used as the model drug.
Xanthan gum (dynamic viscosity 1470 mPa s, according to
the supplier), purchased from Capsifar, Oeiras, Portugal,
was employed as the main binder. Microcrystalline cellu-
lose powder (MCC) (Microcel® 101) obtained from Sagran,
Milan, Italy, was the support excipient. Lactose monohy-
drate (LAC) (mean particle diameter 32.04m. Granulac®
200, Meggle, Wasserburg, Germany), tribasic calcium phos-
phate (TCP) (mean particle diameter 15.72m, Lusifar, Lis-
bon, Portugal) and -cyclodextrin (-CD) (mean particle
diameter 59.60m, Kleptose®, Roquette, Lestrem, France)
were used as filler. Povidone (Kolidon® K30, BASF) was
purchased from Lusifar, Lisbon, Portugal, and employed as
a secondary binder. All the materials were used as received
without further treatment. The granulation liquid was a so-
lution (50% v/v) consisting of distilled water and ethanol
95% (commercial grade).
3. Methods
3.1. Powder particle size determination
The particle size determination of the fillers (lactose, tri-
basic calcium phosphate, and -cyclodextrin) was carried
out in a Malvern Master Sizer (Series 2600C, Malvern In-
struments Ltd., Malvern, UK). The mean values for the par-
ticle diameter by volume are presented (n = 3).
3.2. Preparation of pellets
Three pellets formulations were prepared. All formula-
tions were based in microcrystalline cellulose, 50% (w/w);
diclofenac sodium as the model drug, 10% (w/w); xanthan
gum as the control release agent, 16% (w/w); povidone as a
secondary binder, 8% (w/w); and filler excipient, 16% (w/w).
Formulation 1 (PF#1) comprised lactose monohydrate as the
filler, while formulations 2 (PF#2) and 3 (PF#3) comprised
tribasic calcium phosphate and -cyclodextrin, respec-
tively. Pellets were prepared by extrusion–spheronisation.
Ethanol/water mixture 50% (v/v) was used as the binding
liquid according to previous work (Santos et al., 2002). Dry
powder mixtures, except for the povidone, were blended
in a planetary mixer for 20 min. Povidone was included in
the formulations as a solution in the binding liquid. The
appropriate total quantity of the liquid, which gave the suit-
able wet mass for extrusion thus the best pellets in terms
of roundness (visual inspection), was determined by trial
and error. The wet masses were extruded in a screen ex-
truder (Caleva model 10, Dorset, England) equipped with
a standard screen 1 mm diameter apertures and rollers ro-
tating at 60 rpm. The extrudates were transferred to the
spheroniser (Caleva model 250, Dorset, England) equipped
with a crosshatch plate (250 mm diameter) and processed
at 1000 rpm rotating speed. The resultant pellets were
dried in a fluid bed processor (Uni-Glatt, Glatt GmbH,
Binzen, Germany) with the inlet air flow at 50 ◦C during
20 min.
3.3. Characterisation of pellets
The characterisation of the pellets was performed on the
1000–1400m sieve fraction obtained using a set of stan-
dard sieves (DIN/ISO 3310-1, Retsch, F. Kurt Retsch GmbH
& Co. Haan, Germany) following a √2 progression from
500 to 2000m of sieve openings. Sieve shaker (AS 200
Control “g”, Retsch GmbH & Co., Haan, Germany) oper-
ated during 15 min with the oscillation height of 1.5 mm.
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3.3.1. Apparent particle density
The apparent particle density of the pellets was deter-
mined using a gas pycnometer (Multipycnometer, Quan-
tachrome Co., UK) with helium as the test gas. All pellet
formulations were analysed in triplicate.
3.3.2. Effective particle density and pore structure
Porosity parameters (intrusion–extrusion isotherms, pore
size distribution, pore surface area and average pore diame-
ters) and effective particle density were assessed using mer-
cury porosimetry (PoreSizer 9320, Micromeritics, Norcross,
GA, USA). The relationship between the intruded volume
of mercury and the intrusion pressure was analysed. The in-
trusion pressures were between 0.01 and 208 MPa. The pore
sizes corresponding to the intrusion pressures were calcu-
lated assuming cylindrical pores and a surface tension for
mercury of 485 mN/m. The mercury/material advancing and
receding contact angles were 130◦. Each pellet formulation
was analysed in triplicate.
3.3.3. Intragranular porosity
The intragranular porosity of pellets (ε) was calculated
according to Eq. (1). The apparent density of the pellets
was measured by picnometry (Section 3.3.1) and effective
density of the pellets was measured by mercury picnometry
(Section 3.3.2). Pellet formulations were analysed in tripli-
cate.
ε = 1− effective density of the pellets
apparent density of the pellets
(1)
3.3.4. Tensile strength
The tensile strength of pellets (σf (s)) of the different for-
mulations was assessed using a universal testing instrument
with a 5 kg load cell (CT-5, Engineering Systems, Notting-
ham, UK). The pellets were strained until failure occurred.
The load was recorded and the tensile strength was calcu-
lated applying the values for the failure load (F) and the
radius of the pellet (R) according to Eq. (2) (Shipway and
Hutchings, 1993; Salako et al., 1998). Fifty pellets of each
formulation were analysed.
σf(s) = 0.4F
πR2
(2)
3.3.5. Image analysis
Size and shape of the pellets were concomitantly derived
using an image analysis system (Seescan solitaire 512, See-
scan, Cambridge, UK) connected to a black and white cam-
era (CCD-4 miniature video camera module, Rengo Co.
Ltd., Toyohashi, Japan), zoom lens (18-108/2.5, Olympus
Co., Hamburg, Germany), and top position cold light source
(Olympus Co., Hamburg, Germany). Aspect ratio of pellet,
Feret diameter and shape factor eR were derived from image
analysis and used for statistical analysis. Shape factor eR is
based on a two-dimensional outline analysis and considers
both the geometrical shape and the surface texture of the ag-
glomerate (Podczeck and Newton, 1994). For the shape fac-
tor eR, a value of unity considers a perfect spheroid although
a value close to 0.6 describes a particle of good sphericity.
One hundred pellets of each formulation were analysed.
3.3.6. Surface roughness
Surface of pellets were analysed by applying a non-
contacting laser profilometer (UBM Microfocus Measure-
ment System, UBM Messtechnik GmbH, Ettlingen,
Germany). The roughness parameters were determined
using the UBSOFT software, which also provides a three-
dimensional profile of the surface of the analysed particle.
The laser spot size was 1m, the aperture angle was 53◦,
and the scanning speed was 100 points/s. The measured
area was a square of 0.25 mm× 0.25 mm dimension with a
resolution of 500 points/mm in both the X- and Y-directions.
The Rtm (mean peak to valley ratio) parameter derived from
the surface roughness measurements was used for the sta-
tistical analysis. It describes the arithmetic average of the
largest height difference, each equivalent to the sum of the
largest peak and the deepest valley derived from the line
scan of a surface profile, in each of 25 rectangles obtained
by splitting the surface into a 5×5 grid. This parameter pro-
vides information about the surface that a two-dimensional
line scan would not detect. Six pellets of each formulation
were analysed.
3.3.7. Specific surface area
Pellets samples were analysed by applying the BET tech-
nique for specific surface area using the gas adsorption tech-
nique with nitrogen as the adsorbate gas (ASAP 2000, Mi-
cromeritics, Norcross, USA). Specific surface area was de-
termined by applying the BET model to the equilibrium
isotherm within pressures of 0.05–0.30 psia. Six experimen-
tal points (BET multipoint) and only one experimental point
(BET single point) were used for calculation. Samples were
outgassed by applying vacuum at room temperature during
24 h prior to the determination of the specific surface area.
Three samples of each pellet formulation were analysed.
3.3.8. Deaggregation of pellets from unlubricated tablets
Tablets of unlubricated pellets were prepared (Section 3.4)
and gently shacked in a Petri dish. The deaggregated pel-
lets obtained were then passed through a standard sieve of
1000m diameter apertures (DIN/ISO 3310-1, Retsch, F.
Kurt Retsch GmbH & Co. Haan, Germany). The pellets re-
tained in the sieve were hereafter referred to as retrieved
pellets.
3.3.9. Degree of compression
Unlubricated pellets were compressed (Section 3.4). The
degree of compression of the pellets was calculated by ap-
plying Eq. (3) (Johansson and Alderborn, 1996) (n = 10).
C% =
Ho −Hp
Ho
× 100 (3)
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where Ho is the estimated height of pellet bed in-die before
compression derived from the poured bulk density and fill
weight of the pellets, and the die diameter. Hp is the height
of the compact. The poured bulk density of the pellets was
determined in a 250 ml glass cylinder (inner diameter of
3.5 cm).
3.4. Statistical analysis
Analysis of variance (ANOVA) was performed using
SPSS version 10.0 for windows (SPSS Inc., Chicago, USA)
employing an error probability of P = 0.05.
3.5. Preparation of tablets
Unlubricated pellets were compressed using a single
punch press (Speca Press–Automatic Press, Speca Ltd.,
Kent, England) at maximum punch pressure of 125 MPa.
Press was equipped with flat-faced punches of 1.00 cm
diameter. Punches and die were lubricated before every
compaction with magnesium stearate suspension (1% w/w
in ethanol). 500 mg (±0.5) sample of pellets of size frac-
tion 1000–1400m were accurately weighed and manually
filled into the die. The prepared tablets were stored in a dis-
eccator at room temperature for at least 48 h before being
subjected to any characterisation to remove any residual
humidity.
3.6. Characterisation of tablets
3.6.1. Mechanical tensile strength
Tablets were compressed diametrically in a material test-
ing machine (Erweka TBH28, Erweka Apparatebau GmbH,
Bizen, Federal Republic of Germany) at a compression rate
of 5 mm/min. The mechanical tensile strength of the tablets
(σ) was calculated according to Fell and Newton (1970)
(Eq. (4)) applying the force needed to fracture the tablet (P)
and the diameter (D) and thickness (T) of the tablet. Ten
tablets of each pellet formulation were analysed.
σ = 2P
πDT
(4)
3.6.2. Total porosity
The total porosity (εTotal) was calculated by applying the
bulk density of the compact and the apparent particle den-
sity of the powder mixture. The bulk density of the tablets
was derived from the dimensions and weight of the com-
pacts as well as the apparent particle density of the pellets
(n = 10).
3.7. Microscopy
Photomicrographs of the pellets and the upper and frac-
ture surfaces of the tablets were taken with a scanning elec-
tron microscope (SEM) (Philips XL20, Philips, Eindhoven,
The Netherlands) for visual inspection of the shape and the
surface texture of pellets before and after compaction, as
well as the mode of compaction of the pellets.
3.8. Dissolution testing
In vitro dissolution tests were performed according to
the USP paddle method using a dissolution apparatus (VK
7000 Dissolution Testing Station, Vankel, Essex, England).
The test employed 1000 ml of pH 7.4 phosphate buffer at
37 ◦C as the dissolution medium and paddles rotating at
100 rpm. Samples were continuously collected and analysed
by UV-Vis spectrophotometer (UV-1603 Shimadzu, Shi-
madzu Co., Kyoto, Japan) at 277.5 nm every 15 min over
24 h. Pellets and tablets were analysed in triplicate.
3.9. Drug release study
Analysis of drug release data derived from the dissolution
tests were fitted to the exponential Eq. (5) (Korsmeyer et al.,
1983).
Mt
Mα
= ktn (5)
where Mt is the amount of drug released at time t, Mα the
nominal total amount of drug, Mt /Mα the fraction of drug
released within the range 0.1–0.6 at time t, k is the kinetic
constant (t−n) that incorporates the properties of the poly-
meric system and the drug, and n is the diffusional exponent
of the drug release that is used to characterise the transport
mechanism. In the case of tablets, n = 0.45 for Case I (Fick-
ian diffusion), n = 0.89 for Case II transport, 0.45 < n <
0.89 for anomalous behaviour (non-Fickian transport).
For the characterisation of drug release rate, the mean
dissolution time (MDT) was calculated according to Eq. (6)
using the n and k values derived from Eq. (5) (Möckel and
Lippold, 1993).
MDT = n
n+ 1k
−1/n (6)
Furthermore, to calculate the approximate contribution of
the diffusional and relaxational mechanisms on the release
of the model drug, data was fitted to the heuristic model
(Eq. (7)) (Alfrey et al., 1966; Ritger and Peppas, 1987;
Peppas and Sahlin, 1989).
Mt
Mα
= k1tm + k2t2m (7)
The first term in the right-hand side of Eq. (7) refers to the
Fickian contribution while the second term being the Case II
erosional contribution. The coefficient m is the purely Fick-
ian diffusion exponent for a device of any geometrical shape
that exhibits controlled release. The value of m (0.43) for the
tablets under investigation was determined from the plot of
aspect ratio of the tablets (diameter/thickness) against diffu-
sional exponent according to Peppas and Sahlin, 1989. Drug
release data was fitted to Eq. (7) by non-linear regression
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analysis using PRISM version 3.03 software for windows
(GraphPad Software Inc., San Diego, CA, USA). The per-
centage of the drug released due to the Fickian mechanism
(Fmech) was calculated according to Eq. (8) whereas the ra-
tio of relaxational (Rmech) over Fickian (Fmech) mechanisms
contribution was calculated according to Eq. (9) (Peppas and
Sahlin, 1989).
Fmech = 11+ (k2/k1)tm (8)
Rmech
Fmech
= k2
k1
tm (9)
4. Results and discussion
4.1. Characterisation of pellets
The physical characteristics of the matrix pellets pre-
pared are presented in Table 1. ANOVA revealed that the
three matrix pellets formulations could be regarded as of
similar sphericity once no statistical difference was noticed
for the shape factor (P = 0.148). It could be noticed a
close relation of the surface roughness of the pellets to the
particle size of the fillers (Section 2). Filler of the smallest
particle size resulted in pellets of smother surface. However,
no significant statistical difference was noticed between the
surface roughness of pellets of the different formulations
(P = 0.246).
Although xanthan gum matrix pellets of the different for-
mulations could be regarded as of similar shape and surface
roughness, their dissimilarity in terms of porosity and re-
sistance against fracture were statistically relevant. Pellets
including TCP were the most porous and more susceptible
to fracture followed by those comprising -CD and LAC,
respectively. The pore size distributions (expressed as the
log differential intrusion volumes versus pore diameter −
log scale) of the pellets are shown (Fig. 1) and were used
for reason of comparison. The pore size distributions of the
pellets were similar but the average pore diameter by vol-
ume (defined as the pore diameter at which 50% of the total
volume of intruded mercury is intruded), which is greatly
affected by the number of large pores, was smaller for pel-
lets comprising tribasic calcium phosphate. All the formu-
lations showed a peak in pore size distribution in the range
of macropores (>0.005m in diameter) (Allen, 1997).
Pore size distribution of pellets comprising -CD or LAC
were quite similar as well as their average pore diameter
by volume reflecting on close average pore diameters and
porosities derived from the mercury intrusion measure-
ments. On the other hand, the inclusion of TCP in matrix
pellets formulation resulted in pellets of pore size distribu-
tion spread towards smaller diameters with smaller average
pore diameter by volume. Therefore, those pellets revealed
to be more porous comprising pores of smaller average
diameter compared to the -CD and LAC pellets.
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Fig. 1. Distribution of pore diameter of pellets PF#1 (), PF#2 () and
PF#3 (	) as a function of the differential mercury intrusion.
4.2. Compression of pellets
Visual examination of the upper and fracture surfaces mi-
crophotographs of the tablets of the different types of matrix
pellets revealed that pellets remained as coherent individual
units after compression even though some cracks could be
observed (Fig. 2). No evidence of different mechanisms of
compression could be noticed.
The three types of pellets formulation showed compress-
ion-induced changes in shape as noticed by the visual
inspection. Pellets were flatted after the process of compres-
sion. It was evidenced a lost of the original curvature of the
pellets that compared satisfactorily with previous reports
(Johansson and Alderborn, 1996, 2001). A clear example
of the induced change of shape during compression is pre-
sented in Fig. 3a and b. SEM revealed marked change in the
shape of the pellets showing zones on the surface of the unit
that became flat. This is an indication that marked pellet
deformation occurred in the same direction of the applied
stress during compression (Johansson et al., 1995). This
also implies that volume reduction of these units could have
been an important change induced during compression. If
the compression process inferred slight change of size but
allowed a distinct change of the spherical shape towards flat
surface, it is supposed that densification of the structure of
the units took place then an increase of the apparent density
of the particles after compression and consequent reduction
of the porosity would be expected. In fact, such increase of
the density was noticed (Table 1). Matrix pellets comprising
TCP had higher increase, raising its density after compres-
sion in approximately 15% of their original apparent density,
while those comprising LAC or -CD slightly increased
276
H
.Santos
et
al./European
Jo
u
rn
al
ofPharm
aceuticalSciences21(2004)271–281
Table 1
Physical characteristics of matrix pelletsa
Pellet
formulation
Apparent particle
densityb (g/cm3)
Apparent particle
densityc (g/cm3)
Effective particle
densityb,d (g/cm3)
Intragranular
porosityb (%)
Specific surface
areab (m2/g)
PF#1 1.517 (0.0008) 1.571 (0.0046) 1.091 28.10 (0.037) 1.159 (0.016)
PF#2 1.625 (0.0001) 1.866 (0.0160) 1.116 31.31 (0.004) 4.851 (0.057)
PF#3 1.503 (0.0006) 1.552 (0.0003) 1.096 27.07 (0.030) 1.118 (0.012)
Mechanical tensile
strength (MPa)
Shape factor,
eR
Roughness
(m)
Degree of
compressibility (%)
Degree of
densification (%)
1.76 (0.439) 0.56 (0.119) 10.847 (2.918) 49.27 (0.317) 3.57 (0.325)
1.32 (0.280) 0.55 (0.123) 8.663 (1.069) 51.32 (0.618) 14.84 (0.980)
1.55 (0.278) 0.53 (0.109) 11.585 (4.160) 50.48 (0.341) 3.26 (0.024)
a Mean value (S.D.).
b For the original pellets.
c For the retrieved pellets.
d Determined by mercury intrusion measurements.
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their density in around 3%. If pellet fragmentation is con-
sidered minimal or non-existent and densification was
limited for the LAC and -CD matrix pellets, then the
high volume reduction of the bed of these pellets (Table 1)
was a result of the repositioning of the units followed by
deformation.
The porosity of the original pellets can influence the
degree of deformation and densification of the individual
pellet (Talukdar et al., 1996). TCP matrix pellets were more
porous, more susceptible to fracture and resulted in a more
compressible structure thus more sensitive to deformation
and densification. An explanation for that observation rises
from the hypothesis that, during compression, the primary
particles within the pellet flow in its structure to find new
relative positions thus being affected by the porosity of
the units. The size of the primary particle is one of the
key factors affecting the above-mentioned repositioning.
TCP, here the filler of smallest particle size, resulted in
matrix pellets of more propensity to repositioning hence
of higher degree of compression and furthermore of higher
densification.
Fig. 2. SEM microphotographs of the fracture surface and the upper surface of tablets of xanthan gum matrix pellets: (a and b) TF#1; (c and d) TF#2;
(e and f) TF#3. The white bar denotes 500m.
Table 2
Physical characteristics of tablets formed from matrix pellets compacted
at 125 MPaa
Tablets Height (mm) Total porosity (%) Tensile strength (MPa)
TF#1 0.470 11.12 (0.545) 1.876 (0.120)
TF#2 0.449 22.52 (0.962) 2.971 (0.453)
TF#3 0.469 6.51 (0.621) 2.383 (0.140)
a Mean value (S.D.).
4.3. Compaction of pellets
Pellets of higher intragranular porosity resulted in tablets
of higher tensile strength (Table 2). Results confirmed that
the porosity of the pellets, ruled by the characteristics of the
type of filler in their composition, is a key factor influencing
the tensile strength of the tablet. In addition, it was observed
that tablets of higher total porosity were of higher tensile
strength. This observation is not in accordance with pre-
vious reports (Johansson and Alderborn, 1996; Johansson
et al., 1995; Nicklasson et al., 1999a,b), which observed
almost independence of the original porosity of the particles
278 H. Santos et al. / European Journal of Pharmaceutical Sciences 21 (2004) 271–281
Fig. 3. SEM microphotographs of xanthan gum matrix pellets: (a) original pellets PF#1; (b) retrieved pellet PF#1; (c) original pellets PF#2; (d) original
pellets PF#3. The white bar denotes 500m.
and the total tablet porosity for agglomerates of the same
composition but of different porosities. Here, the total tablet
porosity was found related with the intragranular porosity
and the mechanical tensile strength of the pellets. However,
results for xanthan gum pellets including LAC or -CD
were not as expected. Nevertheless the similarities of the
porous structure of these two types of pellets seem to be a
reasonable explanation.
All three matrix pellets formulations resulted in very close
degrees of compression. Nevertheless, pellets including TCP
were the most compressible although resulted in tablets of
higher total porosity and simultaneously densified. Accord-
ing to observations of the SEM microphotographs of the
surface of facture of the tablets, it could not be inferred
any great difference in the deformation modes of the dif-
ferent kinds of pellets. Hypothetically, TCP matrix pellets
should be more elastic thus more deformable than matrix
units comprising LAC or -CD, according to the results for
the mechanical tensile strength.
Analysis of the results revealed that the matrix pellets of
higher degree of compression resulted in tablets of higher
tensile strength. These pellets revealed to be more suscep-
tible to compression since they were of smaller mechani-
cal tensile strength thus more elastic and less brittle than
the others. Such behaviour is probably consequence of the
filler solubility in the liquid used for wet granulation dur-
ing the preparation of the pellets, i.e., for the water-soluble
fillers lactose and -cyclodextrin, the crystallisation of the
dissolved particles during the drying process of the wet-
ted pellets resulted in a greater degree of close interparticu-
late contact hence less elastic and more brittle agglomerates
(Dyer et al., 1994; Santos et al., 2002).
4.4. Dissolution test and drug release studies
Plots of the fraction of drug released versus time for the
three matrix pellets formulations and their respective tablets
are shown in Fig. 4. The release of the model drug from
all the three different pellets formulations was immediate.
During the test the pellets absorbed water showing extensive
swelling and released their entire drug content due to the
disruption of the structure. Pellets comprising the specified
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Fig. 4. Fraction of diclofenac sodium released (Mt /Mα) from pellets PF#1
(), PF#2 () and PF#3 (); and tablets made of pellets TF#1 (),
TF#2 (	) and TF#3 (), as a function of release time, t.
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amount of that gum (16% w/w) could not maintain the in-
tegrity of the structure and sustain drug release over the ex-
perimental time. On the other hand, tablets made of matrix
pellets tested under the same conditions showed similar be-
haviour: penetration of the medium into the core followed by
swelling of the structure, but the integrity of the structure was
kept except for tablets formed from matrix pellets compris-
ing TCP. The structure behaved as a swollen sponge-like ar-
rangement slowing drug release over the experimental time.
Drug release from the tablets was a result of hydration of
the xanthan gum, which swelled at a great extension forming
a barrier through which drug diffused. Erosion of the tablets
was probably an important mechanism of drug release since
gradual lost of size of the swollen tablets was noticed by
visual inspection during dissolution. Visual examination of
the remaining tablets comprising lactose matrix pellets af-
ter completion of the dissolution tests revealed that the in-
ner core of the cylindrical tablets remained intact without
further penetration of the medium. This explains the incom-
plete release of the model drug after the period of 24 h of
dissolution test.
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Fig. 5. Fraction contribution of the Fickian diffusion () and the erosion () mechanisms from tablets made of pellets formulation as a function of
release time (a) TF#1 (k1 = 0.0104 min−0.43 and k2 = 9.57× 10−4 min−0.86); (b) TF#3 (k1 = 0.0123 min−0.43 and k2 = 11.44× 10−4 min−0.86).
It is noteworthy that the tablets made of matrix pellets
did not function as multiparticulate systems and remained as
monolithic systems, which granted the release control of the
model drug. Visual inspection of the tablets during dissolu-
tion also revealed that the swollen tablets were constituted
of swollen pellets at the surface of the tablets that gradu-
ally eroded and then replaced by inner swollen units as the
medium liquid penetrated the tablet. Initially it was observed
a burst effect for the tablets of pellets comprising TCP, 60%
of the model drug was released in the first hours, which the
majority corresponded to the content of deaggregated pel-
lets from the surface of the tablet. Following, small amounts
of the drug were released until the complete disruption of
the swollen tablet took place then releasing its residual drug
content.
To elucidate the possible release mechanism, the release
rates (Mt /Mα min−1) were analysed based on the method
proposed by Korsmeyer et al. (1983) (Section 3.9). The re-
lease behaviour of the tablets was found to be anomalous
(non-Fickian) having release exponent values (n) 0.7059 and
0.6251 for the tablets formed from LAC and -CD matrix
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Table 3
Values of release kinetic constants (k1: Fickian mechanism; k2: relaxational mechanism), release exponent (n), coefficient of determination (R2) and mean
dissolution time (MDT) for tablets made of matrix pellets
Tablet formulation Model k1 k2 n R2 MDT (min)
TF#1 1a 0.0044 min−0.7059 – 0.7059 0.9993 901.88
2b 0.0104 min−0.43 9.57 × 10−4 min−0.86 – 0.9853 –
TF#3 1a 0.0086 min−0.6251 – 0.6251 0.9984 775.07
2b 0.0123 min−0.43 11.44 × 10−4 min−0.86 – 0.9889 –
a Mt /Mα = k1tn.
b Mt /Mα = k1tm + k2t2m, where m = 0.43 for the tablets under investigation and according to Peppas and Sahlin, 1989.
pellets, respectively (Table 3). Previous works reported that
Fickian diffusion through the hydrated xanthan gum ma-
trix is not the only mechanism accounting for drug release
(Sujja-areevath et al., 1996; Sujja-areevath et al., 1998).
Swelling and erosion occur concurrently resulting in moving
frontier conditions, which continuously modifies the diffu-
sivity of the drug. The effectiveness of xanthan gum as a hy-
drophilic polymer capable of slowing drug release is due to
its high swelling and solvent penetration rate coupled with
its moderate erosion rate (Sujja-areevath et al., 1998).
The fraction of the model drug released from tablet of
-CD matrix pellets is higher than that from tablet of LAC
matrix pellets since the beginning of dissolution. The overall
release rate of the model drug from tablets TF#3 is higher
than that from tablets TF#1. Such observation is in accor-
dance with the derived values for the kinetic constant k1 and
is confirmed by the smaller MDT value (∼13 h) for tablets
of -CD pellets and higher MDT value (∼15 h) for tablets
of LAC pellets (Table 3). This is indicative that the proper-
ties of the tablets and, probably, the properties of the original
pellets constituting the tablets are influencing the release of
the model drug.
To investigate the Fickian diffusion and relaxational
(erosion) mechanisms over the first 60% of drug release
for tablet formulations TF#1 and TF#3, the values of the
Fickian constant k1 and the relaxational constant k2 were
calculated (Table 3). The estimated contributions of the
two mechanisms are shown graphically in Fig. 5. Both
Fickian constants k1 and relaxational constants k2 for the
two tablet formulations were very close. Fickian diffusion
was predominant during the first 4 h of the dissolution time
while polymer erosion gradually increased then became
the predominant mechanism for the rest of dissolution
time. Such behaviour is well explained by the increase of
thickness of the viscous gel layer around the matrix that
creates a longer path length for diffusion which is followed
by polymer chain relaxation, disentanglement and erosion
(Sujja-areevath et al., 1998).
5. Conclusion
Permanent deformation of the pellets was found to be the
most relevant mechanism involved in the compression of
these units. Evidence of fragmentation of the pellets during
the compression process was noticed, however such occur-
rence was limited to very little extension and regarded as not
relevant. In addition to permanent deformation, densifica-
tion was considered as a significant mechanism of compres-
sion since not only the visual examinations detected such
occurrence but also the physical analysis results supported
its importance.
Pellet’s matrix integrity was destroyed in the first hour of
dissolution test due to the disruption of the agglomerate’s
structure probably because of the excessive swelling of the
gum. For the tablets made of pellets, destruction of the ma-
trix integrity was only noticed for those made of pellets
comprising tribasic calcium phosphate as the filler. Possibly
this was a result of increased total porosity of the tablet due
to drug release.
Tablets made of xanthan gum pellets comprising lactose
or -cyclodextrin did not function as multiparticulate sys-
tems. Nevertheless drug release over the dissolution period
was controlled for both of the monolithic systems. For
those systems, drug release behaviour was characterised by
anomalous (non-Fickian) diffusion transport mechanism.
Furthermore, it is inferred that drug diffusion and erosion
are competing mechanisms of drug release from those sys-
tems. Fickian diffusion was predominant during the first 4 h
of dissolution then relaxational mechanism dominated until
the end of the test.
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